ONO PHARMACEUTICAL : Phase 2 Objective Response Rates and Survival Data for Opdivo (nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at the 2014 Chicago Multidisciplinary Symposium on Thoracic…

… types overseas, including: Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC … patients with refractory squamous cell lung cancer after their disease has progressed … for Human Use (CHMP). About Lung Cancer Lung cancer is the leading cause of …